loadpatents
name:-0.025743007659912
name:-0.021783113479614
name:-0.015287160873413
Harrington; Paul E. Patent Filings

Harrington; Paul E.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Harrington; Paul E..The latest application filed is for "macrocyclic compounds that inhibit mcl-1 protein".

Company Profile
11.21.21
  • Harrington; Paul E. - Thousand Oaks CA
  • HARRINGTON; Paul E. - Camarillo CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Macrocyclic compounds that inhibit MCL-1 protein
Grant 11,279,712 - Brown , et al. March 22, 2
2022-03-22
Compounds that inhibits MCL-1 protein
Grant 11,224,601 - Harrington , et al. January 18, 2
2022-01-18
Substituted oxazines as beta-secretase inhibitors
Grant 10,947,223 - Allen , et al. March 16, 2
2021-03-16
Thiazine derivatives as .beta.-secretase inhibitors and methods of use
Grant 10,889,579 - Bourbeau , et al. January 12, 2
2021-01-12
Cyclopropyl fused thiazine derivatives as beta-secretase inhibitors and methods of use
Grant 10,889,581 - Allen , et al. January 12, 2
2021-01-12
Compounds that inhibit Mcl-1 protein
Grant 10,821,115 - Harrington , et al. November 3, 2
2020-11-03
Macrocyclic Compounds That Inhibit Mcl-1 Protein
App 20200247821 - Kind Code
2020-08-06
Cyclopropyl Fused Thiazine Derivatives As Beta-secretase Inhibitors And Methods Of Use
App 20200231585 - ALLEN; Jennifer R. ;   et al.
2020-07-23
Oxazine Derivatives As Beta-secretase Inhibitors And Methods Of Use
App 20200207747 - ALLEN; Jennifer R. ;   et al.
2020-07-02
Compounds That Inhibit Mcl-1 Protein
App 20200171043 - HARRINGTON; Paul E. ;   et al.
2020-06-04
Compounds that inhibit Mcl-1 protein
Grant 10,632,128 - Harrington , et al.
2020-04-28
Thiazine Derivatives As Beta-secretase Inhibitors And Methods Of Use
App 20200062743 - BOURBEAU; Matthew P. ;   et al.
2020-02-27
Compounds That Inhibit Mcl-1 Protein
App 20190381064 - HARRINGTON; Paul E. ;   et al.
2019-12-19
Compounds That Inhibit Mcl-1 Protein
App 20180289720 - Harrington; Paul E. ;   et al.
2018-10-11
Cyclopropyl Fused Thiazin-2-amine Compounds As Beta-secretase Inhibitors And Methods Of Use
App 20170267673 - ALLEN; Jennifer R. ;   et al.
2017-09-21
Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use
Grant 9,611,261 - Minatti , et al. April 4, 2
2017-04-04
Amino-dihydrothiazine and amino-dioxido dihydrothiazine compounds as beta-secretase antagonists and methods of use
Grant 9,556,135 - Lewis , et al. January 31, 2
2017-01-31
Cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use
Grant 9,550,762 - Allen , et al. January 24, 2
2017-01-24
Heteroaryloxycarbocyclyl Compounds as PDE 10 Inhibitors
App 20160280703 - Allen; Jennifer R. ;   et al.
2016-09-29
Perfluorinated Cyclopropyl Fused 1,3-oxazin-2-amine Compounds As Beta-secretase Inhibitors And Methods Of Use
App 20160280695 - MINATTI; Ana Elena ;   et al.
2016-09-29
Cyclopropyl Fused Thiazin-2-Amine Compounds as Beta-Secretase Inhibitors and Methods of Use
App 20160046618 - ALLEN; Jennifer R. ;   et al.
2016-02-18
Amino-dihydrothiazine And Amino-dioxido Dihydrothiazine Compounds As Beta-secretase Antagonists And Methods Of Use
App 20150259308 - Lewis; Richard T. ;   et al.
2015-09-17
Perfluorinated Cyclopropyl Fused 1,3-oxazin-2-amine Compounds As Beta-secretase Inhibitors And Methods Of Use
App 20150252011 - Minatti; Ana Elena ;   et al.
2015-09-10
Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use
Grant 9,085,576 - Minatti , et al. July 21, 2
2015-07-21
Heteroaryloxycarbocyclyl compounds as PDE10 inhibitors
Grant 8,952,037 - Allen , et al. February 10, 2
2015-02-10
Aryl- and heteroaryl- nitrogen-heterocyclic compounds as PDE10 inhibitors
Grant 8,946,230 - Allen , et al. February 3, 2
2015-02-03
Perfluorinated Cyclopropyl Fused 1,3-oxazin-2-amine Compounds As Beta-secretase Inhibitors And Methods Of Use
App 20140275058 - MINATTI; Ana Elena ;   et al.
2014-09-18
Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitors
Grant 8,759,532 - Allen , et al. June 24, 2
2014-06-24
Amino-dihydrothiazine And Amino-dioxido Dihydrothiazine Compounds As Beta-secretase Antagonists And Methods Of Use
App 20140107109 - LEWIS; Richard T. ;   et al.
2014-04-17
Aminopyridine and carboxypyridine compounds as phosphodiesterase 10 inhibitors
Grant 8,637,500 - Allen , et al. January 28, 2
2014-01-28
Pyridine And Pyrimidine Derivatives As Phosphodiesterase 10 Inhibitors
App 20130079325 - Allen; Jennifer R. ;   et al.
2013-03-28
Calcium receptor modulating agents
Grant 8,349,831 - Coulter , et al. January 8, 2
2013-01-08
Calcium receptor modulating agents
Grant 8,334,317 - Coulter , et al. December 18, 2
2012-12-18
Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitors
Grant 8,318,718 - Allen , et al. November 27, 2
2012-11-27
Aryl- And Heteroaryl- Nitrogen-heterocyclic Compounds As Pde10 Inhibitors
App 20110306590 - Allen; Jennifer R. ;   et al.
2011-12-15
Heteroaryloxycarbocyclyl Compounds As Pde10 Inhibitors
App 20110306591 - Allen; Jennifer R. ;   et al.
2011-12-15
Calcium Receptor Modulating Agents
App 20110178133 - Coulter; Thomas S. ;   et al.
2011-07-21
Calcium receptor modulating agents
App 20080221101 - Coulter; Thomas S. ;   et al.
2008-09-11
Company Registrations
SEC0001289440Harrington Paul E

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed